On February 6, 2020, the U.S. Department of Health & Human Services (HHS) published its annual draft rule governing core provisions of the Affordable Care Act (ACA), including the operation of the marketplaces, standards for individual and small-group market health plans, and premium stabilization programs. This expert perspective focuses on several policies that would have implications for state insurance regulation and the operation of the state-based marketplaces (SBMs). Comments on the rule are due March 2, 2020.
The SUPPORT Act: New Tools in Medicaid to Address the Opioid Epidemic
Every day, an average of more than 115 Americans die from an opioid overdose, reflecting a crisis that has evolved – but not dissipated. Following several months of bipartisan, bicameral hearings, markups, and negotiations about how to address the opioid epidemic, the Senate on October 3 passed H.R. 6, The Substance Use Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act (the “SUPPORT Act”). On October 25, President Trump signed the legislation. On November 16, State Health and Value Strategies hosted a webinar, with technical experts from Manatt Health, on the SUPPORT Act. Most stakeholders agree that the bill is a significant step forward in addressing the opioid epidemic, reflecting a range of important policy changes such as initiatives to increase access to medication-assisted treatment (MAT), new grant, pilot and demonstration projects, and a series of changes to Medicaid and Medicare. During this webinar, experts from Manatt Health reviewed major health provisions of the new law and implications for states.